Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Personalized versus standard parenteral nutrition in preterm infants >1250 g
2018-004946-41Phase 4Active
- Sponsor
- Dr. Virgilio P. Carnielli,
- Start
- Jul 2019
- Modality
- Small Molecules, Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised trial of l-leucine, Clinoleic and glucose in Growth disorder and metabolic tolerance to parenteral nutrition (2 arms), sponsored by Dr. Virgilio P. Carnielli,. Primary endpoint: Daily weight change during parenteral nutrition. Started Jul 2019; status: active.
02
Drugs
l-leucineClinoleicglucose
03
Conditions
Growth disordermetabolic tolerance to parenteral nutrition
Beyond the preview
Go deeper on 2018-004946-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-004946-41.